Rescuing the last-line polymyxins: achievements and challenges

SC Nang, MAK Azad, T Velkov, QT Zhou, J Li - Pharmacological reviews, 2021 - ASPET
Antibiotic resistance is a major global health challenge and, worryingly, several key Gram
negative pathogens can become resistant to most currently available antibiotics. Polymyxins …

[PDF][PDF] 中国鲍曼不动杆菌感染诊治与防控专家共识

陈佰义, 何礼贤, 胡必杰, 倪语星, 邱海波, 石岩, 施毅… - 2012 - img.medsci.cn
[编者按] 鲍曼不动杆菌已成为21 世纪临床重要致病茵. 鲍曼不动杆菌基因组研究发现其具有快速
获得和传播耐药性的能力, 多重耐药, 广泛耐药, 全耐药鲍曼不动杆菌已呈世界性流行 …

Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models

MJ McConnell, L Actis, J Pachón - FEMS microbiology reviews, 2013 - academic.oup.com
Acinetobacter baumannii has emerged as a medically important pathogen because of the
increasing number of infections produced by this organism over the preceding three …

2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis

AR Tunkel, R Hasbun, A Bhimraj… - Clinical Infectious …, 2017 - academic.oup.com
Abstract The Infectious Diseases Society of America (IDSA) Standards and Practice
Guidelines Committee collaborated with partner organizations to convene a panel of 10 …

Nosocomial bacterial meningitis

D van de Beek, JM Drake… - New England Journal of …, 2010 - Mass Medical Soc
Nosocomial bacterial meningitis is most often related to either complicated head trauma or
invasive procedures, such as craniotomy, placement of ventricular catheters, intrathecal …

Advances in treatment of bacterial meningitis

D Van de Beek, MC Brouwer, GE Thwaites, AR Tunkel - The Lancet, 2012 - thelancet.com
Bacterial meningitis kills or maims about a fifth of people with the disease. Early antibiotic
treatment improves outcomes, but the effectiveness of widely available antibiotics is …

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

DE Karageorgopoulos, ME Falagas - The Lancet infectious diseases, 2008 - thelancet.com
Institutional outbreaks caused by Acinetobacter baumannii strains that have acquired
multiple mechanisms of antimicrobial drug resistance constitute a growing public-health …

Multiresistant Acinetobacter baumannii infections: epidemiology and management

J Garnacho-Montero… - Current opinion in …, 2010 - journals.lww.com
The optimal treatment for multidrug-resistant A. baumannii nosocomial infections has not
been established. Carbapenems are the mainstay of treatment in susceptible isolates …

[HTML][HTML] Task force on management and prevention of Acinetobacter baumannii infections in the ICU

J Garnacho-Montero, G Dimopoulos, G Poulakou… - Intensive care …, 2015 - Springer
Introduction Acinetobacter baumannii constitutes a dreadful problem in many ICUs
worldwide. The very limited therapeutic options available for these organisms are a matter of …

Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii

G Wan, L Ruan, Y Yin, T Yang, M Ge… - International journal of …, 2016 - Taylor & Francis
Acinetobacter baumannii resistance to carbapenem antibiotics is a serious clinical
challenge. As a newly developed technology, silver nanoparticles (AgNPs) show some …